Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11105 - 11112 of 12008 results

To Release Or Not to Release – If That Is the Question, What Is the Answer?
April 5, 2013| Advisory| Viewpoint

Termination of Rutgers basketball coach highlights importance of employment advice to athletic departments
April 4, 2013| Blog| Viewpoint

CMS Sets Dates for Accepting Another Round of MSSP ACO Applications
April 3, 2013| Blog| Viewpoint

Sixth Circuit Rules No FCA Liability Based on Violation of Medicare Requirements
April 3, 2013| Blog| Viewpoint

CMS Publishes 2014 Final Call Letter
April 2, 2013| Blog| Viewpoint

Hannaford Data Breach Class Action Certification: Denied
April 2, 2013| Blog| Viewpoint

Will Federal Protection for EHR Donations Be Extended Beyond December 31, 2013?
March 29, 2013| Blog| Viewpoint

Important Changes to Form I-94
March 29, 2013| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|
